Six essential digital capabilities to accelerate cell and gene therapy R&D

There is an undeniable change sweeping over the fields of cell and gene therapy. After decades of research and the first drug approvals just a few years ago, these promising drug modalities have entered a new era of industrialization. In the race to address unmet medical needs with more targeted biopharmaceuticals, new challenges have come into focus.